期刊文献+

透明质酸眶下区联合注射在面部年轻化中的应用 被引量:5

Application of combined injection of hyaluronic acid in infraorbital region rejuvenation
原文传递
导出
摘要 目的探讨应用透明质酸联合注射泪沟和眶下区的安全性及有效性。方法自2014年1月至2015年10月,共52例患者接受透明质酸注射填充于泪沟和眶下区域。根据患者下眶缘老化的程度设计不同的注射区域,采用泪沟联合眶缘和眶下区的注射方法。术后随访1—12个月,拍摄照片,评价疗效。结果本组52例患者注射后即刻,1、3、6、12个月疗效维持率分别为98.08%、94.23%、82.70%、42.30%和19.23%。注射后所有患者均有轻度肿胀、皮肤发红等症状,其中5例局部有轻微淤青,1周后自行消退;无感染、血肿、过敏或栓塞等严重并发症发生。4种透明质酸注射后,其并发症和疗效方面无明显差异。结论应用透明质酸注射填充能暂时矫正泪沟和眶下区的老化,是安全和有效的方法;将下眶缘作为一个整体联合注射的效果要优于单纯泪沟注射。 Objective To investigate the safety and effectiveness of hyaluronic acid in combination with the injection of tear trough and infraorbital area. Methods From January 2014 to October 2015, 52 patients were performed the hyaluronic acid injection to fill the orbital rim and infraorbital region. According to the aging degree of the orbital rim, different injection regions were designed and the combined injection of the orbital rim and infraorbital region was adopted. After 1 to 12 months following up, the pictures were taken and the effects were evaluated. Results All the 52 patients were treated with immediate, 1,3,6 and 12 months, and the ef- ficacy maintenance rate was 98.08%, 94.23% , 82.70%, 42.30% and 19.23%. After injection, all patients were with mild swelling, redness and other symptoms, 5 cases were with local slight bruises which were gradu- ally vanished at 1 week. There were no complications, like infection, hematoma, allergy or embolism and other serious occurring. There was no significant difference in the complications and efficacy of the 4 kinds of hyalu- ronie acid. Conclusion It is safe and effective for the temporary correction of the aging of the lacrimal groove and infraorbital region by using hyaluronic acid. The effect of the combined injection of the lower orbital rim as a whole is better than that of a single lacrimal groove.
出处 《中国美容整形外科杂志》 CAS 2016年第1期9-12,共4页 Chinese Journal of Aesthetic and Plastic Surgery
关键词 泪沟 眶下区 透明质酸 面部年轻化 Lacrimal groove Infraorbital region Hyaluronic acid Rejuvenation
  • 相关文献

参考文献20

  • 1Greco TM, Antunes MB, Yellin SA. Injectable fillers for volume re- placement in the aging face[ J ]. Facial Plast Surg, 2012,28 (1) :8-20.
  • 2Kane MA. Nonsurgical periorbital and brow rejuvenation[ J]. Plast Reconstr Surg, 2015,135 ( 1 ) :63-71.
  • 3Hamra ST. The role of the septal reset in creating a youthful eye- lid-cheek complex in facial rejuvenation [ J ]. Plast Reconstr Surg, 2004,113 (7) :2124-2141.
  • 4Ciuci PM, Obagi S. Rejuvenation of the periorbital complex with autologous fat transfer: Current therapy [ J]. J Oral Maxillofac Surg, 2008,66 (8) : 1686-1693.
  • 5Cetinkaya A, Devoto MH. Periocular fat gTafting: indications and techniques [ J ]. Curr Opin Ophthalmol, 2013,24 ( 5 ) :494 -499.
  • 6Lennon FE, Singleton PA. Hyaluronan regulation of vascular in- tegrity[ J]. Am J Cardiovasc Dis, 2011,1(3) :200-213.
  • 7Viana GA, Osaki MH, Cariello A J, et al. Treatment of the tear trough deformity with hyaluronic acid[J]. Aesthet Surg J, 2011, 31 (2) :225-231.
  • 8Rzany B, Cartier H, Kestermont P, et al. Correction of tear troughs and periorbital lines with a range of customized hyaluronic acid fill- ers [ J ]. J Drugs Dermatol, 2012,11 ( 1 Suppl) : s27-s34.
  • 9张兰芳.骨膜表面注射透明质酸治疗鼻唇沟老化的临床疗效观察[J].中国医疗美容,2014,4(5):69-70. 被引量:4
  • 10张梦菡,吴华,石杭燕,严晟,陈达,郭金才,潘蕾,吴溯帆.透明质酸注射矫正泪槽畸形[J].中国美容整形外科杂志,2012,23(10):580-583. 被引量:6

二级参考文献46

  • 1American Society of Plastic Surgeons. National Plastic Surgery [EB/OL]. [ 2012-06-20]. http://~vww, plasticsurgery, org/ News-and-Resources/2011-Statistics-. html.
  • 2Viana GA, Osaki MH, Cariello A J, et al. Treatment of the tear trough deformity with hyaluronic acid [ J ]. Aesthet Surg J, 2011,31 (2) :225-231.
  • 3Dayan SH, Arkins JP, Somenek M. Restylane persisting in lower eyelids for 5 years [ J ]. J Cosmet Demmtol, 2012,11 (3) : 237- 238.
  • 4Matarasso SL, Carruthers JD, JeweU ML; Restylane Consensus Group. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane) [ J ]. Plast Reconstr Surg, 2006,117(3 Suppl):3S-43S.
  • 5Rebecca T, Arlene MR, Kelly P, et al. Brighter eyes: combined upper cheek and tear trough augmentation: a systematic approach utilizing two complementary hyaluronic acid riflers [ J ]. J Drugs Dermatol, 2012,11 (9) :1094-1097.
  • 6Lowe N J, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: review[ J]. Dermatol Sttrg, 2005,31 ( 11 Pt 2 ) : 1616- 1625.
  • 7Friedman PM, Mafong EA, Kauvar AN, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation[J]. Dermatol Surg, 2002,28(6) :491-494.
  • 8Coleman SR; Plastic Surgery Educational Foundation DATA Committee. Cross-linked hyaluronic acid fillers [ J ]. Plast Reconstr Surg, 2006 ,117(2) :661-665.
  • 9Park SW, Woo SJ, Park KH, et al. Iatrogenic retinal artery occlusion caused by cosmetic facial filler injections[ J]. Am J Ophthalmol, 2012,154(4) :653-662. el.
  • 10Kane MA. Treatment of tear trough deformity and lower lid bowing with injectable hyaluronie acid [ J ]. Aesthetic Plast Surg, 2005,29 ( 5 ) : 363 -367.

共引文献21

同被引文献47

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部